Bio-IT World July 29, 2019
Natural language processing (NLP) is finding novel applications at Novo Nordisk, turning a trio of real-world data (RWD) sources into a goldmine of knowledge about the medicines it makes, the healthcare providers who prescribe them, and patients who usually pay for a portion of the cost. Novo Nordisk leverages the NLP text-mining tool of Linguamatics to create efficiencies and generate actionable insights enterprise-wide, winning the company an Innovative Practices Award at the recent Bio-IT World Conference & Expo ’19 in Boston.
NLP is most typically used within the life sciences industry to select targets for the drug discovery process, according to Thierry Breyette, associate director of information analytics at Novo Nordisk. Some companies have also begun using NLP to assist...